- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dan Crippen Discusses Reform of State Medicaid Programs
Dan Crippen, executive director of the National Governors Association, says the single biggest issue with state Medicaid programs is its significant impact on state budgets.
Dan Crippen, executive director of the National Governors Association, says the single biggest issue with state Medicaid programs is its significant impact on state budgets.
“Until recently, states top spending item was education,” says Mr Crippen. “Healthcare, and Medicaid in particular, has crossed that line and is now the most expensive program in the states.”
“Governors’ are looking very hard at the patients that cost the most, why they cost the most, and how we can change those practice or patterns to reduce their costs,” he said.
In fact, each state is creating a strategic action plan to address successful implementation of Medicaid programs.
Medicaid’s high costs make it a challenge to fund many state programs including education, transportation, infrastructure, and other state priorities. However, Mr Crippen suggests that state governors are working to shift their emphasis to controlling Medicaid expenditures while still providing patients with quality care.
Semaglutide Shows Promise for MASH Resolution, Severe Fibrosis: Naim Alkhouri, MD
May 9th 2025Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated steatohepatitis (MASH) and severe fibrosis.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
